Clinical Trial Update: INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial NCT04445844 (IRENE study) combines INCMGA00012 with Pelareorep for metastatic triple-negative breast cancer; the study is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• INCMGA00012
• Pelareorep (pelareorep)

Snippet

Sponsor: Mridula George, MD | Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING